Back to UBS Group AG UBS Group AG

APVOAPVO
3 quarters

Position history for UBS Group AGUBS Group AG's holdings in APTEVO THERAPEUTICS INC

UBS Group AG holds 730 shares of APVO (APTEVO THERAPEUTICS INC), worth $3,242 as of 2026-Q2. The position was decreased (-78.8% shares).

Current Value

$3,242

Current Shares

730

Total Value Change

+$1,639

Total Shares Change

+560

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
730
-78.8%
$3,2420.0%$4.44
0
2026-Q1
Increased
3,445
+1926.5%
$14,7100.0%$6.66
20
2025-Q4
New
170
-
$1,6030.0%$9.39
17

Other major holders of APVO: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used